openPR Logo
Press release

LungCancerSymptoms.org Aims To Boost Awareness Of Warning Signs Of Lung Cancer

12-13-2011 07:20 AM CET | Health & Medicine

Press release from: LungCancerSymptoms.org

Beaverton, Oregon, USA - LungCancerSymptoms.org, a leading provider of information on lung cancer, today highlighted the need to increase awareness of the early symptoms of lung cancer, if deaths from this disease are to be brought down.

"Lung cancer killed over 156,000 people during 2011 in the United States alone. Many of those deaths occurred because the disease was not diagnosed at an early stage when it would have been possible to treat it with greater success. For death rates to decline, everyone needs to become aware of the common symptoms of lung cancer," said Richard Miller, a health researcher with LungCancerSymptoms.org.

The firm's website provides extensive information on all aspects of lung cancer, covering diagnostic methods, disease staging, treatment options and more. It also features a blog to highlight new developments and provide useful tips on dealing with the disease.

According to Miller, while many common lung cancer symptoms also occur with other less serious health conditions, too many people who have these symptoms choose to ignore them. This results in thousands of cases of cancer progressing to a stage where they cannot be cured. The company aims to reverse this trend by showing people what warning signs to look for and encouraging them to seek medical attention when any of those signs are present.

Complete details can be found at http://www.lungcancersymptoms.org.

LungCancerSymptoms.org makes the latest developments on lung cancer available to the layperson, with simple, easy-to-understand explanations of medical issues. The objective is to spread awareness of the disease so that instances of lung cancer are diagnosed early enough to save lives. http://www.lungcancersymptoms.org.

LungCancerSymptoms.org
Richard Miller
4120 Sycamore Street
San Francisco, CA 94104
Ph: 408-961-9684
press@lungcancersymptoms.org
http://www.lungcancersymptoms.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LungCancerSymptoms.org Aims To Boost Awareness Of Warning Signs Of Lung Cancer here

News-ID: 203750 • Views:

More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor